REAL-WORLD EFFECTIVENESS AND SAFETY OF NON-VITAMIN K ANTAGONIST ORAL ANTICOAGULANTS (NOAC) IN PATIENTS WITH NON-VALVULAR ATRIAL FIBRILLATION (NVAF): A RETROSPECTIVE COHORT STUDY IN SINGAPORE

被引：0
|
作者：
Foo, W. [1 ]
Hui, T. [2 ]
Ong, S. K. B. [1 ]
Ng, K. H. [1 ]
机构：
[1] Agcy Care Effectiveness, Minist Hlth, Singapore, Singapore
[2] Agcy Care Effectiveness, Minist Hlth, Singapore 01, Singapore
来源：
VALUE IN HEALTH | 2022年 / 25卷 / 07期
关键词：
D O I：
暂无
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
P73
引用
收藏
页码：S303 / S303
页数：1
相关论文
共 50 条
  • [1] AN APPRAISAL OF REAL-WORLD EVIDENCE (RWE) IN PATIENTS WITH NON-VALVULAR ATRIAL FIBRILLATION (NVAF) TREATED WITH NON-VITAMIN K ANTAGONIST ORAL ANTICOAGULANTS (NOACS)
    Deitelzweig, S.
    Cichewicz, A.
    DiFusco, M.
    Kang, A.
    Russ, C.
    Snook, K.
    Bergrath, E.
    Earley, A.
    Cappelleri, J. C.
    [J]. VALUE IN HEALTH, 2019, 22 : S120 - S120
  • [2] Effectiveness and safety of non-vitamin K antagonist oral anticoagulants in octogenarian patients with non-valvular atrial fibrillation
    Kim, Hyue Mee
    Choi, Eue-Keun
    Park, Chan Soon
    Cha, Myung-Jin
    Lee, Seo-Young
    Kwon, Joon-Myung
    Oh, Seil
    [J]. PLOS ONE, 2019, 14 (03):
  • [3] Effectiveness and Safety of Non-Vitamin K Antagonist Oral Anticoagulants Among Patients With Non-Valvular Atrial Fibrillation and Diabetes
    Deitelzweig, Steve
    Keshishian, Allison
    Li Xiaoyan
    Dhamane, Amol
    Luo Xuemei
    Balachander, Neeraja
    Rosenblatt, Lisa
    Mardekian, Jack
    Pan Xianying
    Nadkarni, Anagha
    Di Fusco, Manuela
    Garcia, Alessandra B.
    Yuce, Huseyin
    Lip, Gregory Y.
    [J]. CIRCULATION, 2018, 138
  • [4] Effectiveness and safety of non-vitamin K antagonist oral anticoagulants in patients with hypertrophic cardiomyopathy with non-valvular atrial fibrillation
    Yunchai Lin
    Hongping Xiong
    Jinzi Su
    Jinxiu Lin
    Qiang Zhou
    Meihua Lin
    Wenxiang Zhao
    Feng Peng
    [J]. Heart and Vessels, 2022, 37 : 1224 - 1231
  • [5] Effectiveness and safety of non-vitamin K antagonist oral anticoagulants in patients with hypertrophic cardiomyopathy with non-valvular atrial fibrillation
    Lin, Yunchai
    Xiong, Hongping
    Su, Jinzi
    Lin, Jinxiu
    Zhou, Qiang
    Lin, Meihua
    Zhao, Wenxiang
    Peng, Feng
    [J]. HEART AND VESSELS, 2022, 37 (07) : 1224 - 1231
  • [6] Effectiveness and Safety of Non-Vitamin K Oral Anticoagulants in Non-Valvular Atrial Fibrillation Patients: Results of A Real-World Study in a Metropolitan Area of Northern Italy
    Crocetti, Emanuele
    Cattaneo, Sarah
    Bergamaschi, Walter
    De Servi, Stefano
    Russo, Antonio Giampiero
    [J]. JOURNAL OF CLINICAL MEDICINE, 2021, 10 (19)
  • [7] A Real-world Experience of the Safety and Efficacy of Non-vitamin K Oral Anticoagulants Versus Warfarin in Patients with Non-valvular Atrial Fibrillation-A Single-centre Retrospective Cohort Study in Singapore
    Tiew, Wen Jun
    Wong, Vivien L. X.
    Tan, Vern Hsen
    Tan, Yong Chuan
    Lee, Elena M. S.
    [J]. ANNALS ACADEMY OF MEDICINE SINGAPORE, 2020, 49 (11) : 838 - 847
  • [8] Real-world efficacy and safety of non-vitamin K antagonist oral anticoagulants in patients with atrial fibrillation
    Francesco Violi
    Daniele Pastori
    [J]. Internal and Emergency Medicine, 2019, 14 : 1199 - 1201
  • [9] Real-world efficacy and safety of non-vitamin K antagonist oral anticoagulants in patients with atrial fibrillation
    Violi, Francesco
    Pastori, Daniele
    [J]. INTERNAL AND EMERGENCY MEDICINE, 2019, 14 (08) : 1199 - 1201
  • [10] Vitamin K and non-vitamin K antagonist oral anticoagulants for non-valvular atrial fibrillation in real-life
    Giustozzi, Michela
    Vedovati, Maria Cristina
    Verdecchia, Paolo
    Pierpaoli, Lucia
    Verso, Melina
    Conti, Serenella
    Cianella, Federica
    Marchesini, Emanuela
    Filippucci, Esmeralda
    Agnelli, Giancarlo
    Becattini, Cecilia
    [J]. EUROPEAN JOURNAL OF INTERNAL MEDICINE, 2016, 33 : 42 - 46
12345